Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GSK PHARMA vs GUJ.INJ(KER) - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    GSK PHARMA GUJ.INJ(KER) GSK PHARMA/
GUJ.INJ(KER)
 
P/E (TTM) x 62.2 229.6 27.1% View Chart
P/BV x 18.9 - - View Chart
Dividend Yield % 1.6 0.0 -  

Financials

 GSK PHARMA   GUJ.INJ(KER)
EQUITY SHARE DATA
    GSK PHARMA
Mar-23
GUJ.INJ(KER)
Mar-23
GSK PHARMA/
GUJ.INJ(KER)
5-Yr Chart
Click to enlarge
High Rs1,68414 11,733.1%   
Low Rs1,2312 53,047.4%   
Sales per share (Unadj.) Rs191.90.4 54,053.2%  
Earnings per share (Unadj.) Rs35.90.1 42,866.8%  
Cash flow per share (Unadj.) Rs39.80.1 47,506.4%  
Dividends per share (Unadj.) Rs32.000-  
Avg Dividend yield %2.20-  
Book value per share (Unadj.) Rs102.9-1.7 -6,023.1%  
Shares outstanding (eoy) m169.414.90 3,457.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.623.5 32.3%   
Avg P/E ratio x40.699.6 40.8%  
P/CF ratio (eoy) x36.799.6 36.8%  
Price / Book Value ratio x14.2-4.9 -290.5%  
Dividend payout %89.20-   
Avg Mkt Cap Rs m246,85841 604,563.6%   
No. of employees `000NANA-   
Total wages/salary Rs m5,9500 2,124,950.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m32,5172 1,868,806.3%  
Other income Rs m1,0074 23,247.3%   
Total revenues Rs m33,5246 553,198.7%   
Gross profit Rs m8,033-4 -213,081.7%  
Depreciation Rs m6580-   
Interest Rs m180-   
Profit before tax Rs m8,3641 1,520,727.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2880 1,633,985.7%   
Profit after tax Rs m6,0760 1,482,053.7%  
Gross profit margin %24.7-216.7 -11.4%  
Effective tax rate %27.426.3 104.2%   
Net profit margin %18.723.6 79.2%  
BALANCE SHEET DATA
Current assets Rs m24,9431 3,563,235.7%   
Current liabilities Rs m13,2647 182,947.6%   
Net working cap to sales %35.9-376.5 -9.5%  
Current ratio x1.90.1 1,947.7%  
Inventory Days Days97488 19.9%  
Debtors Days Days2160-  
Net fixed assets Rs m6,9882 299,903.0%   
Share capital Rs m1,69449 3,467.9%   
"Free" reserves Rs m15,735-57 -27,499.9%   
Net worth Rs m17,430-8 -208,237.8%   
Long term debt Rs m04 0.0%   
Total assets Rs m31,9303 1,053,808.3%  
Interest coverage x462.60-  
Debt to equity ratio x0-0.5 -0.0%  
Sales to assets ratio x1.00.6 177.3%   
Return on assets %19.113.6 140.7%  
Return on equity %34.9-4.9 -710.8%  
Return on capital %48.1-13.2 -365.4%  
Exports to sales %00-   
Imports to sales %48.10-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m15,630NA-   
Fx inflow Rs m1,6220-   
Fx outflow Rs m15,6300-   
Net fx Rs m-14,0080-   
CASH FLOW
From Operations Rs m4,8421 913,632.1%  
From Investments Rs m8,079NA 40,392,550.0%  
From Financial Activity Rs m-15,433NA-  
Net Cashflow Rs m-2,5121 -465,270.4%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 11.6 0.0 -  
FIIs % 2.9 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 100.0 25.0%  
Shareholders   114,663 6,775 1,692.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare GSK PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on GSK Pharma vs GUJ.INJ(KER)

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

GSK Pharma vs GUJ.INJ(KER) Share Price Performance

Period GSK Pharma GUJ.INJ(KER) S&P BSE HEALTHCARE
1-Day 3.26% -4.60% 1.18%
1-Month -9.77% -29.88% -0.75%
1-Year 52.63% 33.20% 61.82%
3-Year CAGR 10.89% 59.98% 18.16%
5-Year CAGR 8.44% 32.57% 19.79%

* Compound Annual Growth Rate

Here are more details on the GSK Pharma share price and the GUJ.INJ(KER) share price.

Moving on to shareholding structures...

The promoters of GSK Pharma hold a 75.0% stake in the company. In case of GUJ.INJ(KER) the stake stands at 0.0%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of GSK Pharma and the shareholding pattern of GUJ.INJ(KER).

Finally, a word on dividends...

In the most recent financial year, GSK Pharma paid a dividend of Rs 32.0 per share. This amounted to a Dividend Payout ratio of 89.2%.

GUJ.INJ(KER) paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of GSK Pharma, and the dividend history of GUJ.INJ(KER).

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.